Skip to content

Effects of neuromuscular blockade on transpulmonary pressure and diaphragm activity in paediatric moderate-to-severe acute respiratory distress syndrome: a pilot study

Effects of neuromuscular blockade on transpulmonary pressure and diaphragm activity in paediatric moderate-to-severe acute respiratory distress syndrome: a pilot study - PedNMB.2

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON45389
Enrollment
19
Registered
2017-03-02
Start date
2017-03-02
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PARDS

Interventions

None listed

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
2 Years to 11 Years

Inclusion criteria

Inclusion criteria: Informed consent Age younger than 12 years Need for mechanical ventilation with tidal volume 5 - 8 mL/kg ideal bodyweight and a mimum PEEP level of 5 cmH2O Early moderate - to - severe paediatric acute respiratory distress syndrome originating from any cause: • Acute onset of disease, and • Oxygenation index > 12, and • One or more (bilateral) infiltrates on chest radiograph, and • No evidence of left ventricular failure or fluid overload, and • Within the first 48 hours of diagnosis of PARDS Indication for continuous infusion of NMBAs at discretion of the attending physician

Exclusion criteria

Exclusion criteria: No informed consent Continuous administration of neuromuscular blockade prior at the time of meeting the criteria for PARDS Chronic respiratory failure on home ventilation Intracranial hypertension Bone marrow transplantation Immunocompromised patients (congenital or acquired) Pre-existing pulmonary hypertension Congenital heart disease with left - to - right shunting Cyanotic congenital heart disease Withdrawal of life - sustaining treatment Prematurity (gestational age less than 44 weeks when assessed for eligibility) History of congenital neuromuscular disorder

Design outcomes

Primary

MeasureTime frame
Transpulmonary pressure

Secondary

MeasureTime frame
Haemodynamic profile, respiratory system mechanics, metrics for oxygenation, ventilation and deadspace, and diaphragmatic activity and occurrence of pendelluft

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)